Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Hancock

Showing results (71-80 of 268) with videos related to

Pageof 27
Sort By:
Frontiers in Cell and Developmental Biology|September 1, 2022
Editorial: Mechanisms guarding the genomeJames A L Brown, E Bourke, W W Hancock, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1988
Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatmentF R Rickles, W W Hancock, R L Edwards, et al.
Transplantation Proceedings|March 20, 1999
Acute rejection of rat renal allografts is accelerated by donor brain deathJ Pratschke, M J Wilhelm, M Kusaka, et al.
Transplantation Proceedings|October 1, 1992
The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapyW W Hancock, A Tsuchida, H Hau, et al.
Transplantation|July 15, 1997
Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejectionB Murphy, K S Kim, R Buelow, et al.
Transplantation|August 19, 2000
Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance inductionS T Smiley, V Csizmadia, W Gao, et al.
Transplantation Proceedings|March 20, 1999
Systemic hypertension accelerates chronic rejection of renal allografts in the ratM Kusaka, F Ziai, W W Hancock, et al.
Immunology Today|August 1, 1996
Delayed xenograft rejectionF H Bach, H Winkler, C Ferran, et al.
Transplantation|July 17, 1998
Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipientsT Miyatake, N Koyamada, W W Hancock, et al.
Transplantation|December 27, 1995
LEW-to-F344 carotid artery allografts: analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responsesW W Hancock, C Shi, M H Picard, et al.
Pageof 27

Showing results (71-80 of 268) with videos related to

Sort By:
Pageof 27
Frontiers in Cell and Developmental Biology|September 1, 2022
Editorial: Mechanisms guarding the genomeJames A L Brown, E Bourke, W W Hancock, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1988
Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatmentF R Rickles, W W Hancock, R L Edwards, et al.
Transplantation Proceedings|March 20, 1999
Acute rejection of rat renal allografts is accelerated by donor brain deathJ Pratschke, M J Wilhelm, M Kusaka, et al.
Transplantation Proceedings|October 1, 1992
The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapyW W Hancock, A Tsuchida, H Hau, et al.
Transplantation|July 15, 1997
Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejectionB Murphy, K S Kim, R Buelow, et al.
Transplantation|August 19, 2000
Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance inductionS T Smiley, V Csizmadia, W Gao, et al.
Transplantation Proceedings|March 20, 1999
Systemic hypertension accelerates chronic rejection of renal allografts in the ratM Kusaka, F Ziai, W W Hancock, et al.
Immunology Today|August 1, 1996
Delayed xenograft rejectionF H Bach, H Winkler, C Ferran, et al.
Transplantation|July 17, 1998
Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipientsT Miyatake, N Koyamada, W W Hancock, et al.
Transplantation|December 27, 1995
LEW-to-F344 carotid artery allografts: analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responsesW W Hancock, C Shi, M H Picard, et al.
Pageof 27